SCIENMAG: Medicine & Health

FEBRUARY 6, 2024

Law enforcement seizures of “magic mushrooms” or “shrooms” containing the psychoactive component psilocybin increased dramatically in the United States between January 2017 and December 2022, according to a new study funded by the National Institute on Drug Abuse, part of the National Institutes of Health.

Drugs 93

Drugs 93

Drug Discovery Today

MAY 26, 2022

The EIT Health Catapult 2022 competition winners, selected from 9 finalists, are digital health start-up, Ebenbuild; medtech start-up, Leuko and biotech start-up, SolasCure. The winners were chosen during this year’s EIT Health Summit at the Karolinska Institutet in Stockholm, which took place 24th-25th May.

113

113

Common Sense for Drug Policy Blog

MAY 2, 2024

Prisoners In 2022 - Statistical Tables. Ann Carson, PhD, and Rich Kluckow, DSW. Washington, DC: US Dept of Justice Bureau of Justice Statistics, November 2023, NCJ307149.

52

52

Drug Channels

OCTOBER 4, 2023

When rebates and discounts were factored in, brand-name drug prices again declined—or grew slowly—in 2022. But for now, the 2022 data provide fresh inconvenient facts for the drug pricing flat earthers (#DPFE). You can find links to each company’s data below. However, some companies had net price gains. See the second chart below.

Pharmaceuticals 86

Pharmaceuticals Drugs 86

Drug Discovery Today

FEBRUARY 4, 2022

• Face-to-face event, taking place in London, UK, 26-27th April, will feature two dedicated tracks: ‘Scientific’, focused on seven core therapy areas and ‘Life Sciences Business’ Programme features keynote from George Freeman MP, with an update on the UK Government Life Sciences VisionRegistration for BioTrinity 2022 now available online

Science 113

Science Government Therapies 113

Drug Channels

JANUARY 18, 2022

Fein, CEO of Drug Channels Institute (DCI), for three live video webinars during 2022. Click here to order the Drug Channels 2022 Video Webinar Series. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. During these events, Dr. Fein will address the latest issues confronting the U.S. drug channel. to 1:30 p.m.

Drugs 88

Drugs Marketing 88

EG Life Sciences

DECEMBER 14, 2022

As we approach the end of 2022, it could not be a better time to go through some important and fascinating breakthroughs from the year that propelled us toward significant advancements within the life sciences space.

Science 52

Science 52

Drug Channels

APRIL 12, 2023

In Drug Channels Institute’s list of the top 15 pharmacies of 2022 , we show that central-fill, mail pharmacies operated by large PBMs and health insurers have displaced retail chains as the largest prescription drug dispensers by revenues.

Specialty Pharmacies 95

Specialty Pharmacies Pharmacy Independent Pharmacies Hospitals 95

Drug Channels

JUNE 13, 2023

When rebates and discounts were factored in, brand-name drug prices again declined—or grew slowly—in 2022. But for now, the 2022 data provide fresh inconvenient facts for the drug pricing flat earthers (#DPFE). You can find links to each company’s data below. However, some companies had net price gains. See the second chart below.

Pharmaceuticals 80

Pharmaceuticals Drugs 80

Common Sense for Drug Policy Blog

JANUARY 5, 2024

Growth in Reports of Xylazine in the US 2019-2022 "In 2019, relatively low rates of xylazine NFLIS [National Forensic Laboratory Information System] reports were observed; all states had a rate below 6 xylazine NFLIS reports per 100,000 residents, and 16 states had zero NFLIS xylazine reports ( Figure 1 ; eTable 4 in Supplement 1 ).

Laboratories 52

Laboratories Drugs 52

Drug Channels

DECEMBER 15, 2023

For 2022, discounted purchases under the 340B program reached a record $53.7 Hospitals accounted for 87% of 340B purchases for 2022. Another surprise: HRSA estimated that manufacturers' contract pharmacy restrictions reduced 340B purchases by only $470 million—or less than 1% of 2022's total purchases. billion (+$2.6

Pharmacy 81

Pharmacy Hospitals Drugs 81

Metabolite Tales Blog

DECEMBER 2, 2022

Hypha’s Q4 2022 newsletter – synthesis of deuterated metabolites In our Q4 2022 newsletter we look at how Hypha make deuterated metabolites, illustrated using case studies where biotransformation and late-stage chemical synthesis techniques were employed.

52

52

Drug Channels

JANUARY 11, 2022

The video is excerpted from my Drug Channels Outlook 2022 video webinar. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. In the video below, I provide a brief overview of key challenges facing retail pharmacy this year. If you missed the live event, you can register to watch a replay. d/b/a Drug Channels Institute.

Pharmacy 78

Pharmacy Drugs 78

Drug Channels

SEPTEMBER 21, 2022

In 2022, specialty pharmacies—via white, brown, and clear bagging—now constitute a meaningful share of the distribution channels for provider-administered oncology drugs. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. The battle for control of the specialty patient continues. Read on for full details and the latest data.

Specialty Pharmacies 74

Specialty Pharmacies Hospitals Pharmacy Pharmaceuticals 74

keypoint

DECEMBER 8, 2022

The December 2022 issue of the Keypoint Newsletter features the latest news and views from Keystone Symposia, including announcement of new CSO Terry Shepard, welcome to the Fellows class of 2023, and Open Access virtual content on Reimagining Scientific Conferences and Climate Health.

52

52

Common Sense for Drug Policy Blog

MAY 2, 2024

Jail Inmates In 2022 - Statistical Tables. Washington, DC: US Department of Justice Bureau of Justice Statistics. December 2023. NCJ307086.

52

52

Drug Channels

SEPTEMBER 24, 2023

For 2022, discounted purchases under the 340B program reached a record $53.7 Hospitals accounted for 87% of 340B purchases for 2022. Another surprise: HRSA estimated that manufacturers' contract pharmacy restrictions reduced 340B purchases by only $470 million—or less than 1% of 2022's total purchases. billion (+$2.6

Pharmacy 70

Pharmacy Hospitals Drugs 70

Cytel

DECEMBER 29, 2022

Here are some of our most read posts of 2022. Perspectives on Enquiry and Evidence explores a wide variety of topics within clinical trial design and data science in the form of expert articles, interviews, ebooks, and more.

Clinical Trials 52

Clinical Trials Trials Science Clinical Development 52

Cytel

DECEMBER 27, 2022

Here are some of our most-read articles on Bayesian methods in 2022. Bayesian methods have been playing a key role in transforming clinical research, providing a variety of new opportunities for efficient and flexible clinical trials. Bayesian topics are frequently explored in Perspectives on Enquiry and Evidence.

Clinical Trials 52

Clinical Trials Clinical Research Trials Research 52

Drug Channels

JANUARY 19, 2022

For 2022, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)— increased the number of drugs they excluded from their standard formularies. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Each exclusion list contains 400 to 500 products.

Biosimilars 95

Biosimilars Pharmacy Drugs Production 95

Drug Channels

JUNE 21, 2022

National Association of Specialty Pharmacy (NASP) 2022 Annual Meeting & Expo. September 19-22, 2022 | Gaylord Palms Resort & Convention Center | Orlando, FL. The National Association of Specialty Pharmacy (NASP) will host the NASP 2022 Annual Meeting & Expo September 19-22. www.naspnet.org/annualmeeting.

Specialty Pharmacies 83

Specialty Pharmacies Pharmacy Nurses Hospitals 83

Drug Channels

MARCH 1, 2022

The Centers for Medicare & Medicaid Services (CMS) has recently released its 2022 data on enrollment in Medicare Part D prescription drug plans (PDPs). Our exclusive analysis of these numbers finds that for 2022, an astounding 99% of seniors are enrolled in the wonderland of PDPs with preferred pharmacy networks. Click to Enlarge].

Pharmacy 98

Pharmacy Marketing Drugs 98

Broad Institute

JULY 25, 2022

Research Roundup: July 25, 2022 By Megan Mandosa-Hayes July 25, 2022 Breadcrumb Home News Research Roundup: July 25, 2022 A widespread cancer gene, exploring nanoparticle uptake, and measuring milestones in autism By Broad Communications July 25, 2022 Credit: Susanna M.

Research 52

Research Science Therapies Drugs 52

Drug Channels

APRIL 20, 2022

Click here to see the original post and comments from January 2022. For 2022, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)— increased the number of drugs they excluded from their standard formularies. d/b/a Drug Channels Institute.

Biosimilars 85

Biosimilars Pharmacy Drugs Production 85

Eye on FDA

JANUARY 26, 2022

FDA’s Office of Prescription Drug Promotion (OPDP) issued the first regulatory action letter for 2022. That said, the last two letters – the final one of 2021 and the first of 2022 both went to the same company – Lilly. This one has some notable characteristics.

FDA 108

FDA Production Drugs Disease 108

Drug Channels

APRIL 11, 2022

Informa Connect's Life Sciences Commercial Contracts & Chargebacks 2022 Hybrid. May 24-25, 2022 | Philadelphia, PA www.informaconnect.com/contracts-chargebacks. Copyright © 2006-2022 Pembroke Consulting, Inc. Save 10% by using code 22DC10. Drug Channels, or any of its employees. d/b/a Drug Channels Institute.

Science 73

Science Pharmaceuticals Drugs 73

LifeSciVC

NOVEMBER 7, 2022

We just held our 2022 Annual General Meeting for our investors, and a few weeks ago convened our Atlas Venture Retreat – both in person for the first time in 3 years. With that context, here’s the Atlas Venture 2022 Year In Review on YouTube. The post Atlas Venture 2022 Year In Review appeared first on LifeSciVC.

Marketing 52

Marketing 52

KIF1A

JUNE 30, 2023

As families, scientists, doctors and our friends around the world navigated the challenges of 2022, the KIF1A.ORG community worked together to reach new heights. Over 162 new families from around the world joined our community since January 2022. What a year! As this community grows, so does our army of advocates and supporters.

Small Molecule 52

Small Molecule Treatment Doctors Research 52

Drug Channels

MAY 17, 2022

Two weeks ago, Paula and I had the pleasure of attending Asembia’s 2022 Specialty Pharmacy Summit at the wonderful Wynn Las Vegas. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Below, I violate Vegas code and tell you what happened there. You’ll also find a link to my general session slides and some fun photos.

Specialty Pharmacies 86

Specialty Pharmacies Pharmacy Drugs Hospitals 86

Drug Channels

JANUARY 21, 2022

On February 22nd at 1:00 pm ET, ConnectiveRx will host Four Big Implications for Patients and the Prescription Journey in 2022 , a free webinar about the pandemic’s impact on key healthcare stakeholders. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Read on for Chris’ insights. d/b/a Drug Channels Institute.

Pharmacy 85

Pharmacy Marketing Drugs 85

keypoint

DECEMBER 8, 2022

By Shannon Weiman 2022 marked an exciting return to in-person meetings after a two year hiatus due to COVID-19. Although we had to delay the beginning of the season due to the Omicron wave in January and February, audiences enthusiastically returned to in-person meetings in March.

52

52

Drug Channels

MARCH 11, 2022

Learn more about AssistRx’s specialty therapy initiation and patient support services at Asembia's Specialty Pharmacy Summit on May 2-5, 2022. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Click here to schedule your meeting. Read on for Stacey’s insights. d/b/a Drug Channels Institute.

Specialty Pharmacies 73

Specialty Pharmacies Pharmacy Therapies Marketing 73

Drug Channels

SEPTEMBER 20, 2022

On October 11, 2022, Drug Channels Institute will release The 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. We are providing you with the opportunity to preorder this thoroughly updated and revised 2022-23 edition at special discounted prices. pharmaceutical distribution industry.

Pharmaceuticals 75

Pharmaceuticals Drugs 75

Drug Channels

MARCH 15, 2022

I am pleased to announce our new 2022 Economic Report on U.S. Prescription Market (press release) We’re offering special discounted pricing if you order before March 28, 2022. The 2022 Economic Report on U.S. The chart below illustrates the depth and breadth of the 2022 edition. Click to Enlarge].

Pharmacy 84

Pharmacy Specialty Pharmacies Licensing Licensing 84

Drug Channels

MARCH 8, 2023

prescription dispensing revenues for calendar year 2022. prescription dispensing revenues reached a record $548 billion in 2022. The exhibit below—one of 241 in our new report—provides a first look at the 15 largest organizations, ranked by total U.S. Not to put too fine a point on it—but they might be giants.

Pharmacy 87

Pharmacy Specialty Pharmacies Marketing Drugs 87

Cytel

DECEMBER 19, 2022

Here are some of our most-read articles on adaptive clinical trials of 2022. Adaptive clinical trial topics are frequently explored in Perspectives on Enquiry and Evidence.

Clinical Trials 52

Clinical Trials Trials Drug Development Drugs 52

Drug Patent Watch

DECEMBER 26, 2022

VICTOZA (liraglutide recombinant) Novo nordisk inc Patent: 8,846,618 Expiration: Dec 27, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact….

Drugs 52

Drugs Pharmaceuticals 52